Insider sale
WEREWOLF THERAPEUTICS, INC.
$27.3K
80.14K shares
What this filing means
UBS ONCOLOGY IMPACT FUND L.P. plans to sell 80.14K shares of WEREWOLF THERAPEUTICS, INC. valued at approximately $27.3K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 7/6/2026ACC: 0001628280-26-047364
10% Owner
Since Apr 2021
80.14K
Shares to sell
$27.3K
Approx. market value
80.14K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Private Placement
Cash
5/4/2021
80.14KTotal acquired80.14K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
5/4/2021 | Private Placement Cash | 80.14K | — |
| Total | 80.14K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
80.14K
Market value
$27.3K
7/6/2026
Total
Units
80.14K
Value
$27.3K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
7/6/2026 | 80.14K | $27.3K | NASDAQ | Planned |
| Total | 80.14K | $27.3K | ||